← All candidates
11 insider filings on record.
11 filings on record.
NBPNovaBridge Biosciences
NasdaqGM · Healthcare · $181.57M
$1.57
-1.26% · Sep 16
11 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 6 sells
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$181.57M
Float
64.5M
56% public
Short % float
Pro
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
6 more transactions on Pro →Context
Wall St
$8.00 avg target
+409.6% vs today · 3 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q4 '25−$0.31 act−$0.23
Q3 '25−$0.06 act−$0.01
Q2 '25−$0.07 act+$0.05
Q1 '25−$0.04 act+$0.03
Coverage
Companies Like NovaBridge Biosciences (NASDAQ:NBP) Can Afford To Invest In GrowthSimply Wall St. · 05-28Insider Spends US$5.1m Buying More Shares In NovaBridge BiosciencesSimply Wall St. · 02-05Is There An Opportunity With NovaBridge Biosciences' (NASDAQ:NBP) 40% Undervaluation?Simply Wall St. · 01-08Amazon downgraded, Roblox upgraded: Wall Street's top analyst callsThe Fly · 02-06
The file stays open
11 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice